CD44 expression in soft tissue sarcomas

Virchows Archiv

Volumn 436, Issue 6, 2000, Pages 574-578

  Kahara, Naoaki ^a   Ozaki, Toshifumi ^a   Doi, Takeshi ^a   Nishida, Keiichiro ^a   Kawai, Akira ^a   Shibahara, Motoi ^a   Inoue, Hajime ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Adhesion molecules; CD44; Prognosis; Soft tissue sarcoma

Indexed keywords

CD44V ANTIGEN; ISOPROTEIN; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION FUNCTION; DERMATOFIBROMA; EXON; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEURILEMOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; CELL MEMBRANE; CHILD; EXONS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROGNOSIS; PROTEIN ISOFORMS; SARCOMA; SOFT TISSUE NEOPLASMS; SURVIVAL RATE;

EID: 0034130662     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004289900159     Document Type: Article

References (24)

1. 1. Alho AM, Underhill CB (1989) The hyaluronate receptor is preferentially expressed on proliferating epithelial cells. J Cell Biol 108:1557-1565
2. 2. Arch R, Wirth K, Hofman M, Ponta H, Matzku S, Herrlich P, Zoller M (1992) Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257: 682-685
3. 3. Enneking WF, Spanier SS, Goodman MA (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 153:106-120
4. 4. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24
5. 5. Guriec N, Marcellin L, Gairard B, Calderoli H, Wilk A, Renaud R, Bergerat JP, Oberling F (1996) Clin Exp Metastasis 14: 434-439
6. 6. Heider K-H, Hoffmann M, Horst E, van den Berg F, Ponta H, Herrlich P, Paris SJ (1993) A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 120:227-233
7. 7. Kainz C, Tempfer C, Winkler S, Sliutz G, Koelbl H, Reinthaller A (1995) Serum CD44 splice variants in cervical cancer patients. Cancer Lett 90:231-234
8. 8. Kaufmann M, Heider KH, Sinn HP, von Mickwitz G, Ponta H, Vollmers HP, Herrlich P, et al (1995) CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345:615-619
9. 9. Lesley J, Hyman R, KincadeP (1993) CD44 and its interaction with extracellular matrix. Adv Immunol 54:271-335
10. 10. Mayer B, Jauch KW, Gunthert U, Figdor CG, Schildberg FW, Funke I, Johnson JP (1993)De novo expression of CD44 and survival in gastric cancer. Lancet 342:1019-1022
11. 11. Miyasaka M (1995) Cancer metastasis and adhesion molecules. Clin Orthop 312:10-18
12. 12. Mulder JW, Kruyt PM, Sewnath M, Costing J, Seldenrijk CA, Weidema WF, Offerhaus GJ, Pals ST (1994) Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 344:1470-1472
13. 13. Nicholson GL (1989) Metastatic tumor cell interactions with endothelium, basement membrane and tissue. Curr Opin Cell Biol 1:1009-1019
14. 14. Ozaki T, Suguhara S, Hamada M, Nakagawa Y, Inoue H (1993) Adjuvant chemotherapy for patients with soft tissue sarcoma. Hiroshima J Med Sci 42:109-115
15. 15. Paget S (1989) Distribution of secondary growths in cancer of breast. Cancer Metastasis Rev 8:98-101
16. 16. Picker LJ, Nakache M, Bukcher EC (1989) Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Biol 109:927-937
17. 17. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89:12160-12164
18. 18. Sliutz G, Temp fer C, Winkler S, Kohlberger P, Reinthaller A, Kainz C (1995) Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer. Br J Cancer 72:1494-1497
19. 19. Stauder R, Eisterer W, Thaler J, Gunthert U (1995) CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood 85:2885-2899
20. 20. Tanabe KK, Ellis LM, Hideyuki S (1993) Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 341:725-726
21. 21. Tempfer C, Gitsch G, Haeusler G, Reinthaller Alexander, Koelbl H, Kainz C (1996) Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva. Cancer 78:273-277
22. 22. Terpe HJ, Koopmann R, Imhof BA, Günthert U (1994) Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas. J Pathol 174: 89-100
23. 23. Wang HH, DeYoung RB, Swanson EP, Wick RM (1996) CD44 immunoreactivity in soft-tissue sarcoma. Appl Immunother 4:184-189
24. 24. Washington K, Gottfried MR, Telen MJ (1994) Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas. Hum Pathol 25:1043-1049